Renaissance Capital logo

EWTX News

US IPO Weekly Recap: Healthcare shines in a 17 IPO week

DRS

In a turbulent week for the IPO market, 17 IPOs and 20 SPACs went public, and one company postponed, defense contractor Leonardo DRS (DRS). While returns cooled off, with just over half of the week’s IPOs finishing below issue, there...read more

Rare disease biotech Edgewise Therapeutics prices upsized IPO at $16 high end

Edgewise Therapeutics logo

Edgewise Therapeutics, a Phase 1 biotech developing small molecule therapies for rare muscle disorders, raised $176 million by offering 11 million shares at $16, the high end of the range of $14 to $16. The company offered 1 million more shares than anticipated....read more

Rare disease biotech Edgewise Therapeutics sets terms for $150 million IPO

Edgewise Therapeutics logo

Edgewise Therapeutics, a Phase 1 biotech developing small molecule therapies for rare muscle disorders, announced terms for its IPO on Monday. The Boulder, CO-based company plans to raise $150 million by offering 10 million shares at a price range of $14 to...read more

US IPO Week Ahead: Cleaning products, crafting machines, and more in a diverse 15 IPO week

DSEY

Updated Monday, 3/22. 15 IPOs are currently scheduled to raise $5.7 billion in the week ahead as IPO activity continues to pick up. The diverse group spans six sectors and includes cleaning products, defense technology, low-cost TVs, crafting...read more